Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Rondo Therapeutics
San Francisco, CA
https://rondotx.com/

Rondo is focused on addressing the significant unmet need for novel immunotherapy approaches capable of treating solid tumors. While T-cell engagers and other bispecific antibodies have shown tremendous success in treating hematologic cancers by engaging a patient's immune system to eliminate tumor cells, translating this success to solid tumors has proved challenging with current approaches and biologic targets. The company, whose founders have deep expertise in bispecific antibody discovery, is committed to leveraging its proprietary immuno-stimulatory platform, to develop first-in-class therapeutics for the treatment of solid tumors.

Key Contact
Name
Shelley Force Aldred
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
03/02/22 $67,000,000 Series A Canaan Partners
Johnson & Johnson Development Corporation (JJDC)
Novo A/S
Red Tree Venture Captial
SV Health Investors
undisclosed